Stroke Prevention and Treatment in Sickle Cell Disease
Arch Neurol 58:565-568, Adams,R.J., 2001
Why Are Stroke Patients Excluded from TPA Therapy?
Neurol 56:1015-1020, Barber,P.A.,et al, 2001
Cerebral Sinus Thrombosis with Tamoxifen
Neurol 56:1113-1114, Finelli,P.F. & Schauer,P.K., 2001
Safety of Intra-Arterial Thrombolysis in the Postoperative Period
Stroke 32:1365-1369, Chalela,J.A.,et al, 2001
Chickenpox and Stroke in Childhood
Stroke 32:1257-1262, Askalan,R.,et al, 2001
Diffusion-weighted Imaging Patterns of Brain Damage Associated with Cerebral Venous Thrombosis
AJNR 22:261-268, Ducreux,D.,et al, 2001
Combined Intraarterial/Intravenous Thrombolysis for Acute Ischemic Stroke
AJNR 22:352-358, Keris,V.,et al, 2001
Intraarterial Thrombolysis: Ready for Prime Time?
AJNR 22:55-58, Executive Committee of the ASITN, 2001
Venous Thromboembolism After Acute Stroke
Stroke 32:262-267, Kelly,J.,et al, 2001
Improved Cerebrovascular Patency Following Therapy in Patients with Sickle Cell Disease: Initial Results in 4 Patients Who Received HLA-Identical Hematopoietic Stem Cell Allografts
Ann Neurol 49:222-229, Steen,R.G.,et al, 2001
Suppression of Recurrent Transient Ischemic Attacks by a Statin Agent
Neurol 56:531-532, Alberts,M.J., 2001
Sustained Bilateral Hemodynamic Benefit of Contralateral Carotid Endarterectomy in Patients with Symptomatic Internal Carotid Artery Occlusion
Stroke 32:728-734, Rutgers,D.R.,et al, 2001
Recurrent Brain Hemorrhage is More Frequent Than Ischemic Stroke After Intracranial Hemorrhage
Neurol 56:773-777, Bailey,R.D.,et al, 2001
Stroke Magnetic Resonance Imaging Within 6 Hours After Onset of Hyperacute Cerebral Ischemia
Ann Neurol 49:460-469, Schellinger,P.D.,et al, 2001
MRI Hyperintensities of the Temporal Lobe and External Capsule in Patients with CADASIL
Neurol 56:628-634, O'Sullivan,M.,et al, 2001
Vertebral Artery Dissection Due to Indirect Neck Trauma: An Underrecognised Entity
Neurol India 49:384-390, Prabhakar,S.,et al, 2001
Cerebral Venous Thrombosis Presenting as Acute Visual Loss
Br J Ophthalmol 85:1139, Ko,Y.-C.,et al, 2001
Venous Infarcts
Neurol Neurochir Pol 34:937-946, Mendel,T., 2000
Combined Intravenous and Intra-Arterial Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
Stroke 31:2552-2557, Ernst,R.,et al, 2000
The Association Between the Diameter of a Patent Foramen Ovale and the Risk of Embolic Cerebrovascular Events
Am J Med 109:456-462,506, Schuchlenz,H.W.,et al, 2000
Pulmonary Arteriovenous Malformations
Neurol 55:959-964, Moussouttas,M.,et al, 2000
Morphological and Functional Characteristics of Patent Foramen Ovale and Their Embolic Implications
Stroke 31:2407-2413, De Castro,S.,et al, 2000
Cerebral Venous Thrombosis: Anticoagulants or Thrombolyic Therapy?
JNNP 69:427-430, Benamer,H.T.S. & Bone,I., 2000
Stroke and Pregnancy
Stroke 31:2948-2951, Jaigobin,C. & Silver,F.L., 2000
Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Stroke 31:2920-2924, Chapman,K.M.,et al, 2000
Corpus Callosum Infarcts with Atypical Clinical and Radiologic Presentations
AJNR 21:1876-1880, Kasow,D.L.,et al, 2000
Subarachnoid Haemorrhage Treated with Anticoagulants
Lancet 356:1818, Ciccone,A.,et al, 2000
Validity and Reliability of a Quantitative Computed Tomography Score in Predicting Outcome of Hyperacute Stroke Before Thrombolytic Therapy
Lancet 355:1670-1674, Barber,P.A.,et al, 2000
Intravenous Ancrod for Treatment of Acute ischemic Stroke
JAMA 283:2395-2403, Sherman,D.G.,et al, 2000
Ancrod-Is Snake Venom an Antidote for Stroke
JAMA 283:2440-2441, Mayberg,M.R.&Furlan,A., 2000
Impact on Stroke Subtype Diagnosis of Early Diffusion-Weighted Magnetic Resonance Imaging and Magnetic Resonance Angiography
Stroke 31:1081-1089, Lee,L.J.,et al, 2000
Transcranial Doppler Ultrasound Criteria for Recanalization After Thrombolysis for Middle Cerebral Artery Stroke
Stroke 31:1128-1132, Burgin,W.S.,et al, 2000
New magnetic Resonance Imaging Methods for Cerebrovascular Disease: Emerging Clinical Applications
Ann Neurol 47:559-570, Neumann-Haefelin,T.,et al, 2000
Magnetic Resonance Venography in Idiopathic Pseudotumor Cerebri
J Neuro-Ophthal 20:12-13, Lee,A.G.&Brazis,P.W., 2000
Feasibility and Practicality of MR Imaging of Stroke in the Management of Hyperacute Cerebral Ischemia
AJNR 21:1184-1189, 1177, Schellinger,P.D. et al, 2000
Comparison of Diffusion-Weighted MRI and CT in Acute Stroke
Neurol 54:1557-1561,1548,1549,1552, Lansberg,M.G.,et al, 2000
Intracranial Vertebrobasilar Stenosis: Angioplasty and Follow-Up
AJNR 21:1293-1301, Nahser,H.C. et al, 2000
Ischemic Stroke in Young Women: Risk of Recurrence During Subsequent Pregnancies
Neurol 55:269-274, Lamy,C. et al, 2000
Stroke Mimicry: Four Cases Eligible for Tissue Plasminogen Activator
The Neurologist 6:220-223, Kirshner, H.S., 2000
Facial Palsy in Cerebral Venous Thrombosis
Stroke 31:1766-1769, Straub,J. et al, 2000
An Uncommon Cause of Recurrent Strokes
Stroke 31:2002-2003, Naegeli,B. et al, 2000
Symptomatic Intracranial Atherosclerosis
Neurol 55:490-497, 465, Thijs,V.N. & Albers,G.W., 2000
Treatment of Acute Ischemic Stroke
NEJM 343:710-722, Brott, T. & Bogousslavsky, J., 2000
Stroke Prevention
Neurol Clin 18:321-341, Wein,T.H. &Bornstein,N.M., 2000
Selective Infusion of Urokinase and Thrombectomy in the Treatment of Acute Cerebral Sinus Thrombosis
AJNR 21:143-145, Novak,Z.,et al, 2000
Superior Sagittal Sinus Thrombosis Due to Lithium:Local Urokinase Thrombolysis Treatment
Neurol 54:532-533, Wasay,M.,et al, 2000
Rate of Stroke Recurrence in Patients with Primary Intracerebral Hemorrhage
Stroke 31:123-127, Hill,M.D.,et al, 2000
Status Epilepticus In Stroke, Report on a Hospital-Based Stroke Cohort
Neurol 54:350-354, Rumbach,L.,et al, 2000
Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 80 Years and Older, The tPa Stroke Survey Experience
Stroke 31:370-375, Tanne,D.,et al, 2000
Treating Acute Stroke Patients with Intravenous tPA, The OSF Stroke Network Experience
Stroke 31:77-81, Wang,D.Z.,et al, 2000